Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Staar Surgical Company (STAA)

Staar Surgical Company (STAA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 874,464
  • Shares Outstanding, K 49,742
  • Annual Sales, $ 313,900 K
  • Annual Income, $ -20,210 K
  • EBIT $ -97 M
  • EBITDA $ -91 M
  • 60-Month Beta 1.06
  • Price/Sales 3.73
  • Price/Cash Flow N/A
  • Price/Book 2.38

Options Overview Details

View History
  • Implied Volatility 76.03% (-5.25%)
  • Historical Volatility 36.72%
  • IV Percentile 69%
  • IV Rank 53.27%
  • IV High 135.13% on 04/16/25
  • IV Low 8.65% on 08/12/25
  • Expected Move (DTE 10) 1.40 (8.06%)
  • Put/Call Vol Ratio 4.83
  • Today's Volume 519
  • Volume Avg (30-Day) 488
  • Put/Call OI Ratio 1.64
  • Today's Open Interest 17,937
  • Open Int (30-Day) 17,860
  • Expected Range 16.01 to 18.81

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.01
  • Number of Estimates 3
  • High Estimate 0.07
  • Low Estimate -0.04
  • Prior Year -0.59
  • Growth Rate Est. (year over year) +101.69%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.94 +2.77%
on 02/05/26
22.68 -23.24%
on 01/12/26
-4.71 (-21.29%)
since 01/09/26
3-Month
16.94 +2.77%
on 02/05/26
28.40 -38.70%
on 11/24/25
-9.14 (-34.43%)
since 11/07/25
52-Week
13.50 +28.96%
on 02/12/25
30.81 -43.49%
on 08/13/25
-4.54 (-20.68%)
since 02/07/25

Most Recent Stories

More News
3 Cash-Burning Stocks with Open Questions

3 Cash-Burning Stocks with Open Questions

PTLO : 6.06 (+1.68%)
STAA : 17.41 (-0.97%)
CTOS : 6.90 (+0.44%)
Why STAAR Surgical (STAA) Stock Is Trading Lower Today

Why STAAR Surgical (STAA) Stock Is Trading Lower Today

STAA : 17.41 (-0.97%)
STAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs

Search Committee Has Initiated a Global Search to Select Next CEO

STAA : 17.41 (-0.97%)
3 Healthcare Stocks Walking a Fine Line

3 Healthcare Stocks Walking a Fine Line

A : 127.50 (-1.61%)
STAA : 17.41 (-0.97%)
MRNA : 41.95 (+2.29%)
STAAR Surgical (STAA): Buy, Sell, or Hold Post Q3 Earnings?

STAAR Surgical (STAA): Buy, Sell, or Hold Post Q3 Earnings?

STAA : 17.41 (-0.97%)
STAAR Surgical and Broadwood Partners Enter Into Cooperation Agreement

Neal Bradsher and Richard LeBuhn of Broadwood and Christopher Wang of Yunqi Capital have Joined STAAR Board STAAR Chair Elizabeth Yeu and CEO Stephen...

STAA : 17.41 (-0.97%)
3 Stocks Under $50 That Fall Short

3 Stocks Under $50 That Fall Short

KMX : 46.46 (-1.51%)
STAA : 17.41 (-0.97%)
PLAB : 37.54 (+0.81%)
Alcon Terminates Agreement to Acquire STAAR Surgical

Ad hoc announcement pursuant to Art. 53 LR

STAA : 17.41 (-0.97%)
ALC : 78.44 (-0.49%)
Broadwood Partners Comments on STAAR Surgical Shareholders’ Rejection of the Company’s Proposed Sale to Alcon

Thanks Fellow Shareholders for Rejecting the Transaction Reiterates Enthusiasm for the Company’s Standalone Prospects ...

STAA : 17.41 (-0.97%)
ALC : 78.44 (-0.49%)
STAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders

STAAR Intends to Terminate Alcon Merger Agreement

STAA : 17.41 (-0.97%)

Business Summary

Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.

See More

Key Turning Points

3rd Resistance Point 18.22
2nd Resistance Point 17.95
1st Resistance Point 17.68
Last Price 17.41
1st Support Level 17.14
2nd Support Level 16.87
3rd Support Level 16.60

See More

52-Week High 30.81
Fibonacci 61.8% 24.20
Fibonacci 50% 22.15
Fibonacci 38.2% 20.11
Last Price 17.41
52-Week Low 13.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar